These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30020422)

  • 21. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).
    Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B;
    Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient Disengagement From an HIV Preexposure Prophylaxis Program in a Sexually Transmitted Disease Clinic.
    Dombrowski JC; Golden MR; Barbee LA; Khosropour CM
    Sex Transm Dis; 2018 Sep; 45(9):e62-e64. PubMed ID: 29485544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do You PrEP? A Review of Primary Care Provider Knowledge of PrEP and Attitudes on Prescribing PrEP.
    Turner L; Roepke A; Wardell E; Teitelman AM
    J Assoc Nurses AIDS Care; 2018; 29(1):83-92. PubMed ID: 29274655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlates of Awareness of and Willingness to Use Pre-exposure Prophylaxis (PrEP) in Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Geosocial-Networking Smartphone Applications in New York City.
    Goedel WC; Halkitis PN; Greene RE; Duncan DT
    AIDS Behav; 2016 Jul; 20(7):1435-42. PubMed ID: 26966013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.
    Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA
    Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
    Suraratdecha C; Stuart RM; Manopaiboon C; Green D; Lertpiriyasuwat C; Wilson DP; Pavaputanon P; Visavakum P; Monkongdee P; Khawcharoenporn T; Tharee P; Kittinunvorakoon C; Martin M
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reaching Key Populations: PrEP Uptake in an Urban Health Care System in the Bronx, New York.
    Bien CH; Patel VV; Blackstock OJ; Felsen UR
    AIDS Behav; 2017 May; 21(5):1309-1314. PubMed ID: 28025734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox".
    Hoffman S; Guidry JA; Collier KL; Mantell JE; Boccher-Lattimore D; Kaighobadi F; Sandfort TG
    J Int Assoc Provid AIDS Care; 2016; 15(1):59-65. PubMed ID: 26293904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy.
    Meyers K; Rodriguez K; Moeller RW; Gratch I; Markowitz M; Halkitis PN
    PLoS One; 2014; 9(12):e114700. PubMed ID: 25502768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York.
    Kessler J; Myers JE; Nucifora KA; Mensah N; Toohey C; Khademi A; Cutler B; Braithwaite S
    AIDS; 2014 Nov; 28(18):2683-91. PubMed ID: 25493594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PrEP Stigma: Implicit and Explicit Drivers of Disparity.
    Golub SA
    Curr HIV/AIDS Rep; 2018 Apr; 15(2):190-197. PubMed ID: 29460223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementing HIV pre-exposure prophylaxis (PrEP): let's not get caught with our pants down.
    Saxton P; Giola M; Coughlan E; Rich J; Azariah S; Ludlam A; O'Toole C; Pohl M; Myers J
    N Z Med J; 2018 Aug; 131(1481):64-73. PubMed ID: 30161114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PrEP Whores and HIV Prevention: The Queer Communication of HIV Pre-Exposure Prophylaxis (PrEP).
    Spieldenner A
    J Homosex; 2016 Dec; 63(12):1685-1697. PubMed ID: 26930025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Academic Detailing to Increase Prescribing of HIV Pre-exposure Prophylaxis.
    Krakower DS; Naja-Riese GM; Edelstein ZR; Gandhi AD; Wahnich A; Fischer MA
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S87-S97. PubMed ID: 34686295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Review of Telehealth Innovations for HIV Pre-Exposure Prophylaxis (PrEP).
    Touger R; Wood BR
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):113-119. PubMed ID: 30701404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UK PrEP decision re-ignites HIV activism.
    The Lancet
    Lancet; 2016 Apr; 387(10027):1484. PubMed ID: 27115959
    [No Abstract]   [Full Text] [Related]  

  • 37. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.
    Siegler AJ; Mouhanna F; Giler RM; Weiss K; Pembleton E; Guest J; Jones J; Castel A; Yeung H; Kramer M; McCallister S; Sullivan PS
    Ann Epidemiol; 2018 Dec; 28(12):841-849. PubMed ID: 29983236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.
    Farmer EK; Koren DE; Cha A; Grossman K; Cates DW
    AIDS Patient Care STDS; 2019 May; 33(5):207-213. PubMed ID: 31067124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and examples of successful health service models of PrEP implementation.
    Zablotska IB; Baeten JM; Phanuphak N; McCormack S; Ong J
    Sex Health; 2018 Nov; 15(6):481-484. PubMed ID: 30496716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.